Wang, J.-J.; Siu, M.K.-Y.; Jiang, Y.-X.; Leung, T.H.-Y.; Chan, D.W.; Wang, H.-G.; Ngan, H.Y.-S.; Chan, K.K.-L.
A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer. Biomolecules 2021, 11, 1749.
https://doi.org/10.3390/biom11121749
AMA Style
Wang J-J, Siu MK-Y, Jiang Y-X, Leung TH-Y, Chan DW, Wang H-G, Ngan HY-S, Chan KK-L.
A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer. Biomolecules. 2021; 11(12):1749.
https://doi.org/10.3390/biom11121749
Chicago/Turabian Style
Wang, Jing-Jing, Michelle Kwan-Yee Siu, Yu-Xin Jiang, Thomas Ho-Yin Leung, David Wai Chan, Huo-Gang Wang, Hextan Yuen-Sheung Ngan, and Karen Kar-Loen Chan.
2021. "A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer" Biomolecules 11, no. 12: 1749.
https://doi.org/10.3390/biom11121749
APA Style
Wang, J.-J., Siu, M. K.-Y., Jiang, Y.-X., Leung, T. H.-Y., Chan, D. W., Wang, H.-G., Ngan, H. Y.-S., & Chan, K. K.-L.
(2021). A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer. Biomolecules, 11(12), 1749.
https://doi.org/10.3390/biom11121749